M. Jung

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1 S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders

Guy Griebel, Jacques Simiand, R. Steinberg et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 236 citations

Medicine, Neuroscience, Pharmacology +17

Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia

Anne Rémaury, Natalio Vita, S. Gendreau et al. · Brain Research · 2002 · 139 citations

Life Sciences, Neurobiology, Neuroscience +15

Selective Blockade of Neurokinin-2 Receptors Produces Antidepressant-Like Effects Associated with Reduced Corticotropin-Releasing Factor Function

R. Steinberg, Richard Alonso, Guy Griebel et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 91 citations

Medicine, Neuroscience, Pharmacology +17

Neuropharmacological characterization of SR 140333, a non peptide antagonist of NK1 receptors

M. Jung, R. Calassi, Jeanne Maruani et al. · Neuropharmacology · 1994 · 60 citations

Medicine, Neuroscience, Pharmacology +7

SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. II: Behavioral Profile Predictive of an Atypical Antipsychotic Activity

Ronan Depoortère, Denis Boulay, Ghislaine Perrault et al. · Neuropsychopharmacology · 2003 · 52 citations · Full text

Medicine, Pharmacology, Psychiatry +17